37 results on '"Manzo, Anna"'
Search Results
2. Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed
3. Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy
4. New perspectives in the second-line treatment of non squamous NSCLC patients: Results from a large Italian Lung Cancer Working Group
5. EGFR Mutations
6. List of Contributors
7. Afatinib: An overview of its clinical development in non-small-cell lung cancer and other tumors
8. Risk Management Activities in a Lung Cancer Multidisciplinary Team at a Comprehensive Cancer Center: Results of a Prospective Analysis
9. BRAF Inhibitors in Non-Small Cell Lung Cancer
10. Lurbinectedin in small cell lung cancer
11. Risk Management Activities in a Lung Cancer Multidisciplinary Team at a Comprehensive Cancer Center: Results of a Prospective Analysis.
12. Liquid Biopsy Testing for the Management of Patient with Non-Small Cell Lung Cancer Carrying a Rare Exon-20 EGFR Insertion
13. RET Inhibitors in Non-Small-Cell Lung Cancer
14. Angiogenesis Inhibitors in Small Cell Lung Cancer
15. Management of EGFR-mutant non-small-cell lung cancer patients after first-line reversible EGF receptor-tyrosine kinase inhibitors
16. Chapter 33 - EGFR Mutations: Best Results from Second- and Third-Generation Tyrosine Kinase Inhibitors
17. Pneumocystis jirovecii Pneumonia in a Patient with Lung Adenocarcinoma and EGFR Mutation Treated with Afatinib During the Coronavirus Pandemic 2019
18. Immunotherapy in Small Cell Lung Cancer
19. The safety of atezolizumab plus chemotherapy for the treatment of metastatic lung cancer
20. Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer
21. Pembrolizumab in lung cancer: current evidence and future perspectives
22. Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial
23. Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials
24. The dead Pigeon River: did Champion International's dioxin pollution create a 'Widowsville' in North Carolina?
25. Angiogenesis Inhibitors in NSCLC
26. Efficacy of the addition of cisplatin to single-agent first-line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): A joint analysis of the multicenter, randomized phase III MILES-3 and MILES-4 studies.
27. P3.02c-092 Nivolumab in Multi-Treated Patients with Advanced Sq-NSCLC: Data from the Italian Cohort of Expanded Access Programme (EAP)
28. Focus on Nintedanib in NSCLC and Other Tumors
29. Italian cohort of nivolumab Expanded Access Programme (EAP): Preliminary data from a real-world population.
30. A multicenter, randomised, phase III trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in advanced SCLC patients. The STAD-1 trial.
31. Metformin in lung cancer: rationale for a combination therapy
32. Critical appraisal of the use of regorafenib in the management of colorectal cancer.
33. The Philippines: another I.M.F. casualty
34. RET Inhibitors in Non-Small-Cell Lung Cancer
35. New perspectives in the second-line treatment of non squamous NSCLC patients: Results from a large Italian Lung Cancer Working Group
36. Afatinib: An overview of its clinical development in non-small-cell lung cancer and other tumors
37. Improving the quality of patient care in lung cancer: key factors for successful multidisciplinary team working.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.